论文部分内容阅读
目的：探讨特布他林加赛庚啶对婴儿气喘和咳嗽的疗效，并与氨茶碱作比较。方法：治疗组３１例（男性２１例，女性１０例，年龄１５±ｓ６ｍｏ）采用特布他林０．０６５ｍｇ／（ｋｇ·ｄ），赛庚啶０．２５ｍｇ／（ｋｇ·ｄ），均分为３次口服。对照组２８例（男性１６例，女性１２例，年龄１６±６ｍｏ）用氨茶碱３～５ｍｇ／（ｋｇ·ｄ），分３次口服。２组综合治疗（地塞米松、镇咳药、抗生素、吸氧）大致相仿。结果：２组总显效率分别是５５％和２５％，治疗组止咳平喘作用显著优于对照组（Ｐ＜０．０５）。结论：特布他林加赛庚啶治疗婴儿气喘和咳嗽的安全性强、疗效较好。
Objective: To investigate the therapeutic effect of terbutaline and cyproheptadine on infant asthma and cough, and to compare with aminophylline. Methods: 31 cases of treatment group (21 males, 10 females, age 15 ± s6mo) were treated with terbutaline 0.065mg / (kg · d), cyproheptadine 0.25mg / (kg · d) Oral 3 times. Control group of 28 patients (16 males and 12 females, aged 16 ± 6mo) with aminophylline 3 ~ 5mg / (kg · d), 3 times orally. Two groups of comprehensive treatment (dexamethasone, antitussive, antibiotics, oxygen) are roughly the same. Results: The total effective rates in two groups were 55% and 25%, respectively. The effect of relieving cough and asthma in the treatment group was significantly better than that in the control group (P <0.05). CONCLUSIONS: The combination of terbutaline and cyproheptadine is safe and effective in infants with asthma and cough.